Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OCTRU is running a one-day course for those wishing to be a chief investigator on the design and conduct of clinical trials on Friday 10th June 2016 at the Botnar Research Centre.

The Oxford skyline

Aim: To provide those wishing to be a chief investigator with a greater understanding of how to design and conduct their own clinical trial and the secrets of a successful funding application.

 

Course objectives:

  • To understand how to develop a good research question
  • To explore the principles of good trial design
  • To know where to apply for trial funding
  • To understand how to write a successful funding application
  • To know how to effectively cost a trial
  • To understand the role of a Clinical Trials Unit

 

Venue: Botnar Research Centre, University of Oxford, Windmill Road, Oxford, OX3 7LF

Target audience: This course is specifically targeted at new investigators who would like to design and conduct their own trial but who have not yet successfully applied for funding.

Cost: £75 

CPD Credits: Approved by the Federation of the Royal College of Physicians for 5 category 1 (external) CPD credit(s)

 

Please note places are limited. Please email octrutrialshub@ndorms.ox.ac.uk for further details.

Similar stories

SCIENCE spreads across the world

Oxford Trauma are pleased to open their first overseas site for the SCIENCE study.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

PRoCuRe opens to recruitment

The Partial Rotator Cuff Tear Repair Trial (PRoCuRe) is open to recruitment at Oxford University Hospitals NHS Foundation Trust after achieving OCTRU Green Light approval!

IMP-MEL Trial given Green Light to open

OCTRU have now given Green Light approval for IMP MEL to open. This is a phase 1 first-in-human dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC.

WISE opens to recruitment

The WISE Study - Wrist Injury Strengthening Exercise: a randomised multicentre feasibility study of resistance exercise versus usual care for optimising function after distal radius fracture in adults aged 50 years or over has now received OCTRU Green Light approval and has opened to recruitment.